EMEA (Europe, Middle East and Africa) Rivaroxaban Market Report 2017

COVID-19
Get in-depth analysis of the COVID-19 impact on this
Market/Industry



In this report, the EMEA Rivaroxaban market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Rivaroxaban for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. EMEA Rivaroxaban market competition by top manufacturers/players, with Rivaroxaban sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Bayer J&J ... On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into 2.5 mg 10 mg 15 mg 20 mg On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Rivaroxaban for each application, including Acute coronary syndrome (ACS) Venous thromboembolism (VTE) If you have any special requirements, please let us know and we will offer you the report as you want.


Table of Contents

EMEA (Europe, Middle East and Africa) Rivaroxaban Market Report 2017
1 Rivaroxaban Overview
    1.1 Product Overview and Scope of Rivaroxaban
    1.2 Classification of Rivaroxaban
        1.2.1 EMEA Rivaroxaban Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Rivaroxaban Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 2.5 mg
        1.2.4 10 mg
        1.2.5 15 mg
        1.2.6 20 mg
    1.3 EMEA Rivaroxaban Market by Application/End Users
        1.3.1 EMEA Rivaroxaban Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Acute coronary syndrome (ACS)
        1.3.3 Venous thromboembolism (VTE)
    1.4 EMEA Rivaroxaban Market by Region
        1.4.1 EMEA Rivaroxaban Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Rivaroxaban (2012-2022)
        1.5.1 EMEA Rivaroxaban Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Rivaroxaban Revenue and Growth Rate (2012-2022)

2 EMEA Rivaroxaban Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Rivaroxaban Market Competition by Players/Manufacturers
        2.1.1 EMEA Rivaroxaban Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Rivaroxaban Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Rivaroxaban Sale Price by Players (2012-2017)
    2.2 EMEA Rivaroxaban (Volume and Value) by Type/Product Category
        2.2.1 EMEA Rivaroxaban Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Rivaroxaban Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Rivaroxaban Sale Price by Type (2012-2017)
    2.3 EMEA Rivaroxaban (Volume) by Application
    2.4 EMEA Rivaroxaban (Volume and Value) by Region
        2.4.1 EMEA Rivaroxaban Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Rivaroxaban Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Rivaroxaban Sales Price by Region (2012-2017)

3 Europe Rivaroxaban (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Rivaroxaban Sales and Value (2012-2017)
        3.1.1 Europe Rivaroxaban Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Rivaroxaban Revenue and Growth Rate (2012-2017)
    3.2 Europe Rivaroxaban Sales and Market Share by Type
    3.3 Europe Rivaroxaban Sales and Market Share by Application
    3.4 Europe Rivaroxaban Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Rivaroxaban Sales Volume by Countries (2012-2017)
        3.4.2 Europe Rivaroxaban Revenue by Countries (2012-2017)
        3.4.3 Germany Rivaroxaban Sales and Growth Rate (2012-2017)
        3.4.4 France Rivaroxaban Sales and Growth Rate (2012-2017)
        3.4.5 UK Rivaroxaban Sales and Growth Rate (2012-2017)
        3.4.6 Russia Rivaroxaban Sales and Growth Rate (2012-2017)
        3.4.7 Italy Rivaroxaban Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Rivaroxaban Sales and Growth Rate (2012-2017)

4 Middle East Rivaroxaban (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Rivaroxaban Sales and Value (2012-2017)
        4.1.1 Middle East Rivaroxaban Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Rivaroxaban Revenue and Growth Rate (2012-2017)
    4.2 Middle East Rivaroxaban Sales and Market Share by Type
    4.3 Middle East Rivaroxaban Sales and Market Share by Application
    4.4 Middle East Rivaroxaban Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Rivaroxaban Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Rivaroxaban Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Rivaroxaban Sales and Growth Rate (2012-2017)
        4.4.4 Israel Rivaroxaban Sales and Growth Rate (2012-2017)
        4.4.5 UAE Rivaroxaban Sales and Growth Rate (2012-2017)
        4.4.6 Iran Rivaroxaban Sales and Growth Rate (2012-2017)

5 Africa Rivaroxaban (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Rivaroxaban Sales and Value (2012-2017)
        5.1.1 Africa Rivaroxaban Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Rivaroxaban Revenue and Growth Rate (2012-2017)
    5.2 Africa Rivaroxaban Sales and Market Share by Type
    5.3 Africa Rivaroxaban Sales and Market Share by Application
    5.4 Africa Rivaroxaban Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Rivaroxaban Sales Volume by Countries (2012-2017)
        5.4.2 Africa Rivaroxaban Revenue by Countries (2012-2017)
        5.4.3 South Africa Rivaroxaban Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Rivaroxaban Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Rivaroxaban Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Rivaroxaban Sales and Growth Rate (2012-2017)

6 EMEA Rivaroxaban Manufacturers/Players Profiles and Sales Data
    6.1 Bayer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Rivaroxaban Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Bayer Rivaroxaban Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 J&J
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Rivaroxaban Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 J&J Rivaroxaban Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    ...

7 Rivaroxaban Manufacturing Cost Analysis
    7.1 Rivaroxaban Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Rivaroxaban

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Rivaroxaban Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Rivaroxaban Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Rivaroxaban Market Forecast (2017-2022)
    11.1 EMEA Rivaroxaban Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Rivaroxaban Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Rivaroxaban Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Rivaroxaban Price and Trend Forecast (2017-2022)
    11.2 EMEA Rivaroxaban Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Rivaroxaban Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Rivaroxaban Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Rivaroxaban Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Rivaroxaban Sales Forecast by Type (2017-2022)
    11.7 EMEA Rivaroxaban Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer



List of Tables and Figures

    Figure Product Picture of Rivaroxaban
    Figure EMEA Rivaroxaban Sales Volume (K Units) by Type (2012-2022)
    Figure EMEA Rivaroxaban Sales Volume Market Share by Type (Product Category) in 2016
    Figure 2.5 mg Product Picture
    Figure 10 mg Product Picture
    Figure 15 mg Product Picture
    Figure 20 mg Product Picture
    Figure EMEA Rivaroxaban Sales Volume (K Units) by Application (2012-2022)
    Figure EMEA Sales Market Share of Rivaroxaban by Application in 2016
    Figure Acute coronary syndrome (ACS) Examples
    Table Key Downstream Customer in Acute coronary syndrome (ACS)
    Figure Venous thromboembolism (VTE) Examples
    Table Key Downstream Customer in Venous thromboembolism (VTE)
    Figure EMEA Rivaroxaban Market Size (Million USD) by Region (2012-2022)
    Figure Europe Rivaroxaban Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Europe Rivaroxaban Revenue (Million USD) Status and Forecast by Countries
    Figure Middle East Rivaroxaban Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Middle East Rivaroxaban Revenue (Million USD) Status and Forecast by Countries
    Figure Africa Rivaroxaban Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Africa Rivaroxaban Revenue (Million USD) Status and Forecast by Countries
    Figure EMEA Rivaroxaban Sales Volume and Growth Rate (2012-2022)
    Figure EMEA Rivaroxaban Revenue (Million USD) and Growth Rate (2012-2022)
    Figure EMEA Rivaroxaban Market Major Players Product Sales Volume (K Units) (2012-2017)
    Table EMEA Rivaroxaban Sales Volume (K Units) of Major Players (2012-2017)
    Table EMEA Rivaroxaban Sales Share by Players (2012-2017)
    Figure 2016 Rivaroxaban Sales Share by Players
    Figure 2017 Rivaroxaban Sales Share by Players
    Figure EMEA Rivaroxaban Market Major Players Product Revenue (Million USD) (2012-2017)
    Table EMEA Rivaroxaban Revenue (Million USD) by Players (2012-2017)
    Table EMEA Rivaroxaban Revenue Share by Players (2012-2017)
    Table 2016 EMEA Rivaroxaban Revenue Share by Players
    Table 2017 EMEA Rivaroxaban Revenue Share by Players
    Table EMEA Rivaroxaban Sale Price (USD/Unit) by Players (2012-2017)
    Table EMEA Rivaroxaban Sales (K Units) and Market Share by Type (2012-2017)
    Table EMEA Rivaroxaban Sales Share by Type (2012-2017)
    Figure Sales Market Share of Rivaroxaban by Type (2012-2017)
    Figure EMEA Rivaroxaban Sales Market Share by Type (2012-2017)
    Table EMEA Rivaroxaban Revenue (Million USD) and Market Share by Type (2012-2017)
    Table EMEA Rivaroxaban Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Rivaroxaban by Type in 2016
    Table EMEA Rivaroxaban Sale Price (USD/Unit) by Type (2012-2017)
    Table EMEA Rivaroxaban Sales (K Units) and Market Share by Application (2012-2017)
    Table EMEA Rivaroxaban Sales Share by Application (2012-2017)
    Figure Sales Market Share of Rivaroxaban by Application (2012-2017)
    Figure EMEA Rivaroxaban Sales Market Share by Application in 2016
    Table EMEA Rivaroxaban Sales (K Units) and Market Share by Region (2012-2017)
    Table EMEA Rivaroxaban Sales Share by Region (2012-2017)
    Figure Sales Market Share of Rivaroxaban by Region (2012-2017)
    Figure EMEA Rivaroxaban Sales Market Share in 2016
    Table EMEA Rivaroxaban Revenue (Million USD) and Market Share by Region (2012-2017)
    Table EMEA Rivaroxaban Revenue Share by Region (2012-2017)
    Figure Revenue Market Share of Rivaroxaban by Region (2012-2017)
    Figure EMEA Rivaroxaban Revenue Market Share Regions in 2016
    Table EMEA Rivaroxaban Sales Price (USD/Unit) by Region (2012-2017)
    Figure Europe Rivaroxaban Sales (K Units) and Growth Rate (2012-2017)
    Figure Europe Rivaroxaban Revenue and Growth Rate (2012-2017)
    Table Europe Rivaroxaban Sales (K Units) by Type (2012-2017)
    Table Europe Rivaroxaban Market Share by Type (2012-2017)
    Figure Europe Rivaroxaban Market Share by Type in 2016
    Table Europe Rivaroxaban Sales (K Units) by Application (2012-2017)
    Table Europe Rivaroxaban Market Share by Application (2012-2017)
    Figure Europe Rivaroxaban Market Share by Application in 2016
    Table Europe Rivaroxaban Sales (K Units) by Countries (2012-2017)
    Table Europe Rivaroxaban Sales Market Share by Countries (2012-2017)
    Figure Europe Rivaroxaban Sales Market Share by Countries (2012-2017)
    Figure Europe Rivaroxaban Sales Market Share by Countries in 2016
    Table Europe Rivaroxaban Revenue (Million USD) by Countries (2012-2017)
    Table Europe Rivaroxaban Revenue Market Share by Countries (2012-2017)
    Figure Europe Rivaroxaban Revenue Market Share by Countries (2012-2017)
    Figure Europe Rivaroxaban Revenue Market Share by Countries in 2016
    Figure Germany Rivaroxaban Sales (K Units) and Growth Rate (2012-2017)
    Figure France Rivaroxaban Sales (K Units) and Growth Rate (2012-2017)
    Figure UK Rivaroxaban Sales (K Units) and Growth Rate (2012-2017)
    Figure Russia Rivaroxaban Sales (K Units) and Growth Rate (2012-2017)
    Figure Italy Rivaroxaban Sales (K Units) and Growth Rate (2012-2017)
    Figure Benelux Rivaroxaban Sales (K Units) and Growth Rate (2012-2017)
    Figure Middle East Rivaroxaban Sales (K Units) and Growth Rate (2012-2017)
    Figure Middle East Rivaroxaban Revenue (Million USD) and Growth Rate (2012-2017)
    Table Middle East Rivaroxaban Sales (K Units) by Type (2012-2017)
    Table Middle East Rivaroxaban Market Share by Type (2012-2017)
    Figure Middle East Rivaroxaban Market Share by Type (2012-2017)
    Table Middle East Rivaroxaban Sales (K Units) by Applications (2012-2017)
    Table Middle East Rivaroxaban Market Share by Applications (2012-2017)
    Figure Middle East Rivaroxaban Sales Market Share by Application in 2016
    Table Middle East Rivaroxaban Sales Volume (K Units) by Countries (2012-2017)
    Table Middle East Rivaroxaban Sales Volume Market Share by Countries (2012-2017)
    Figure Middle East Rivaroxaban Sales Volume Market Share by Countries in 2016
    Table Middle East Rivaroxaban Revenue (Million USD) by Countries (2012-2017)
    Table Middle East Rivaroxaban Revenue Market Share by Countries (2012-2017)
    Figure Middle East Rivaroxaban Revenue Market Share by Countries (2012-2017)
    Figure Middle East Rivaroxaban Revenue Market Share by Countries in 2016
    Figure Saudi Arabia Rivaroxaban Sales (K Units) and Growth Rate (2012-2017)
    Figure Israel Rivaroxaban Sales (K Units) and Growth Rate (2012-2017)
    Figure UAE Rivaroxaban Sales (K Units) and Growth Rate (2012-2017)
    Figure Iran Rivaroxaban Sales (K Units) and Growth Rate (2012-2017)
    Figure Africa Rivaroxaban Sales (K Units) and Growth Rate (2012-2017)
    Figure Africa Rivaroxaban Revenue (Million USD) and Growth Rate (2012-2017)
    Table Africa Rivaroxaban Sales (K Units) by Type (2012-2017)
    Table Africa Rivaroxaban Sales Market Share by Type (2012-2017)
    Figure Africa Rivaroxaban Sales Market Share by Type (2012-2017)
    Figure Africa Rivaroxaban Sales Market Share by Type in 2016
    Table Africa Rivaroxaban Sales (K Units) by Application (2012-2017)
    Table Africa Rivaroxaban Sales Market Share by Application (2012-2017)
    Figure Africa Rivaroxaban Sales Market Share by Application (2012-2017)
    Table Africa Rivaroxaban Sales Volume (K Units) by Countries (2012-2017)
    Table Africa Rivaroxaban Sales Market Share by Countries (2012-2017)
    Figure Africa Rivaroxaban Sales Market Share by Countries (2012-2017)
    Figure Africa Rivaroxaban Sales Market Share by Countries in 2016
    Table Africa Rivaroxaban Revenue (Million USD) by Countries (2012-2017)
    Table Africa Rivaroxaban Revenue Market Share by Countries (2012-2017)
    Figure Africa Rivaroxaban Revenue Market Share by Countries (2012-2017)
    Figure Africa Rivaroxaban Revenue Market Share by Countries in 2016
    Figure South Africa Rivaroxaban Sales (K Units) and Growth Rate (2012-2017)
    Figure Nigeria Rivaroxaban Sales (K Units) and Growth Rate (2012-2017)
    Figure Egypt Rivaroxaban Sales (K Units) and Growth Rate (2012-2017)
    Figure Algeria Rivaroxaban Sales (K Units) and Growth Rate (2012-2017)
    Table Bayer Rivaroxaban Basic Information List
    Table Bayer Rivaroxaban Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Bayer Rivaroxaban Sales (K Units) and Growth Rate (2012-2017)
    Figure Bayer Rivaroxaban Sales Market Share in EMEA (2012-2017)
    Figure Bayer Rivaroxaban Revenue Market Share in EMEA (2012-2017)
    Table J&J Rivaroxaban Basic Information List
    Table J&J Rivaroxaban Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure J&J Rivaroxaban Sales (K Units) and Growth Rate (2012-2017)
    Figure J&J Rivaroxaban Sales Market Share in EMEA (2012-2017)
    Figure J&J Rivaroxaban Revenue Market Share in EMEA (2012-2017)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Rivaroxaban
    Figure Manufacturing Process Analysis of Rivaroxaban
    Figure Rivaroxaban Industrial Chain Analysis
    Table Raw Materials Sources of Rivaroxaban Major Manufacturers in 2016
    Table Major Buyers of Rivaroxaban
    Table Distributors/Traders List
    Figure EMEA Rivaroxaban Sales (K Units) and Growth Rate Forecast (2017-2022)
    Figure EMEA Rivaroxaban Revenue and Growth Rate Forecast (2017-2022)
    Figure EMEA Rivaroxaban Price (USD/Unit) and Trend Forecast (2017-2022)
    Table EMEA Rivaroxaban Sales (K Units) Forecast by Region (2017-2022)
    Figure EMEA Rivaroxaban Sales Market Share Forecast by Region (2017-2022)
    Table EMEA Rivaroxaban Revenue (Million USD) Forecast by Region (2017-2022)
    Figure EMEA Rivaroxaban Revenue Market Share Forecast by Region (2017-2022)
    Table Europe Rivaroxaban Sales (K Units) Forecast by Countries (2017-2022)
    Figure Europe Rivaroxaban Sales Market Share Forecast by Countries (2017-2022)
    Table Europe Rivaroxaban Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Europe Rivaroxaban Revenue Market Share Forecast by Countries (2017-2022)
    Table Middle East Rivaroxaban Sales (K Units) Forecast by Countries (2017-2022)
    Figure Middle East Rivaroxaban Sales Market Share Forecast by Countries (2017-2022)
    Table Middle East Rivaroxaban Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Middle East Rivaroxaban Revenue Market Share Forecast by Countries (2017-2022)
    Table Africa Rivaroxaban Sales (K Units) Forecast by Countries (2017-2022)
    Figure Africa Rivaroxaban Sales Market Share Forecast by Countries (2017-2022)
    Table Africa Rivaroxaban Revenue (Million USD) Forecast by Countries (2017-2022)
    Figure Africa Rivaroxaban Revenue Market Share Forecast by Countries (2017-2022)
    Table EMEA Rivaroxaban Sales (K Units) Forecast by Type (2017-2022)
    Figure EMEA Rivaroxaban Sales Market Share Forecast by Type (2017-2022)
    Table EMEA Rivaroxaban Sales (K Units) Forecast by Application (2017-2022)
    Figure EMEA Rivaroxaban Sales Market Share Forecast by Application (2017-2022)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources


Let our analyst help you with a customized solution for your market research needs

Select the license

Credit card Logo
hkjkhjkhjkhjkmjhjhkhjkjkhjkhjkm
Discount  Check Discount Question  Enquiry Before
   Purchase
hkjkhjkhjkhjkmjhjhkhjkjkhjkhjkm
fgfhfhfgf